Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HaCaT |
Human epidermal keratinocyte cell line | Human | skin | cell line | adherent | plasmid | Metafectene PRO | publication | L. Stixová et al., Life, 2021, 11, 669, doi.org/10.3390/life11070669 | Link | |||
HaCaT |
Human epidermal keratinocyte cell line | Human | skin | cell line | adherent | plasmid | K4 Multiplier | publication | Z. Regdon et al., Br. J. Pharmacol.,2021, 178: 1095–1113, DOI: 10.1111/bph.15344 | Link | |||
HaCaT |
Human epidermal keratinocyte cell line | Human | skin | cell line | adherent | plasmid | K2 Transfection System | publication | V. Morales-Garcia et al., FEBS Open Bio 10, 2020, 2541–2552, doi:10.1002/2211-5463.12987 | ||||
HaCaT |
Human epidermal keratinocyte cell line | Human | skin | cell line | adherent | plasmid | Metafectene PRO | publication | W. Xiao et al., Free Radical Biology and Medicine, 2013, 65: 70–77, doi.org/10.1016/j.freeradbiomed.2013.06.010 | ||||
HaCaT |
Human keratinocyte cell line | Human | skin | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
HaCaT |
Human keratinocyte cell line | Human | skin | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
||||
GR-M |
Human cutaneous melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Venza et al., Biochem. and Biophys. Res. Commun., 2013, 441: 743–750, doi.org/10.1016/j.bbrc.2013.10.114 | |||
G361 |
Human skin malignant melanoma cell line | ATCC CRL-1424 | Human | skin | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
G361 |
Human skin malignant melanoma cell line | ATCC CRL-1424 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Pigment Cell Melanoma Res., 2013, 26: 900–911, doi: 10.1111/pcmr.12144 | ||
G361 |
Human skin malignant melanoma cell line | ATCC CRL-1424 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Venza et al., Biochem. and Biophys. Res. Commun., 2013, 441: 743–750, doi.org/10.1016/j.bbrc.2013.10.114 | ||
CMel-2 |
Human primary superficial spreading melanoma cells | Human | skin | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Venza et al., Int. Immunopharmacol., 2014, 21: 439–446; doi.org/10.1016/j.intimp.2014.05.024 | |||
CMel-2 |
Human primary superficial spreading melanoma cells | Human | skin | primary cell | adherent | plasmid | Metafectene PRO | publication | I. Venza et al., Int. Immunopharmacol., 2014, 21: 439–446; doi.org/10.1016/j.intimp.2014.05.024 | ||||
A431 |
Human epidermoid carcinoma cell line | ATCC CRL-1555 | Human | skin | cell line | adherent | plasmid | Metafectene PRO | publication | H. Kobayashi et al., J. Biol. Chem., Nov 2011; 286: 39259 - 39268 | Link | ||
A431 |
Human epidermoid carcinoma cell line | ATCC CRL-1555 | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. Rungaldier et al., PLOSONE, June 2017, https://doi.org/10.1371/journal.pone.0178646 | Link | |
A431 |
Human epidermoid carcinoma cell line | ATCC CRL-1555 | Human | skin | cell line | adherent | plasmid | Metafectene | publication | S. Rungaldier et al., PLOSONE, June 2017, https://doi.org/10.1371/journal.pone.0178646 | Link | ||
A431 |
Human epidermoid carcinoma cell line | ATCC CRL-1555 | Human | skin | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
A431 |
Human epidermoid carcinoma cell line | ATCC CRL-1555 | Human | skin | cell line | adherent | plasmid | Metafectene | publication | E. Umlauf et al., J. Biol. Chem., May 2004; 279: 23699 - 23709 | Link | ||
A375-P |
Human melanona cell line | ATCC CRL-3224 | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Raturi et al., J. Cell Biol., Aug 2016; 214, 433 - 444 | ||
A375-P |
Human melanona cell line | ATCC CRL-3224 | Human | skin | cell line | adherent | plasmid | Metafectene | publication | A. Raturi et al., J. Cell Biol., Aug 2016; 214, 433 - 444 | |||
A375-P |
Human melanona cell line | ATCC CRL-3224 | Human | skin | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | A. Raturi et al., J. Cell Biol., Aug 2016; 214, 433 - 444 | ||
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | plasmid | RNA-Interference | K2 Transfection System | publication | M. Tufano et al., Front. Cell Dev. Biol., 2021, 9: 718947, doi: 10.3389/fcell.2021.718947 | Link | |
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Clinical and Translational Medicine, 2014, 3:1, doi:10.1186/2001-1326-3-1 | Link | |
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | minicircle | Metafectene | publication | D. Kobelt, Dissertation, 2012, Humboldt-Universität zu Berlin | Link | ||
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | D. Konina et al., Int. J. Mol. Sci., 2021, 22, 8477, doi.org/10.3390/ijms22168477 | Link | |
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | plasmid | Metafectene | publication | A. Y. Filatova et al., Europ. J. of Human Genetics, 2019, 27: 488–493 |